Navigation Links
Non-GMO solution to seafood allergies

Seafood allergy sufferers may soon be able to eat prawns without the fear of an adverse reaction. Chinese scientists have taken a promising step towards removing from prawns the proteins that cause an allergic response without resorting to genetic manipulation, reports Lisa Richards in Chemistry & Industry, the magazine of the SCI.

Li Zhenxing led the research at the Ocean University of China. The team revealed that treating prawns with a combination of heat and irradiation significantly reduced the level of reactive proteins called allergens. They took blood from patients with shrimp allergies, added samples of treated and untreated prawn, and measured how antibodies in the blood reacted. They found that levels of ‘Pen a 1? one of the major allergens, decreased 20-fold after treatment (Journal of the Science of Food and Agriculture DOI 10.1002/jsfa.2746).

Zhenxing’s team suggests that irradiation damages the proteins, revealing hidden reactive amino acid residues. Subsequent heating then destroys the exposed residues. "Radiation and heat seems to be a promising method for reducing the immunoreactivity" say the researchers.

Samuel Lehrer of Tulane University in New Orleans, USA, is already working on removing allergens from prawns using genetic techniques. But Zhenxing’s method could be preferable for people wary of eating genetically modified foods.
'"/>

Source:Society of Chemical Industry


Page: 1

Related biology news :

1. New law for resolution allows unprecedented sharpness in fluorescence microscopy
2. A radical solution for environmental pollution
3. Scientists must offer solutions for conserving tropical forests in a rapidly changing world
4. UCR environmental scientists propose chemical solution to cleaning Californias Salton Sea
5. High resolution snapshots detail dynamics of a cocaine antibody
6. High-resolution light microscope reveals the fundamental mechanisms of nerve communication
7. Microscopic scaffolding offers a simple solution to treating skin injuries
8. Recombination protein dynamics observed with single monomer resolution
9. A sweet solution for Alzheimers disease?
10. Plant-cell-produced technologies-cutting edge approach to bringing solutions to the market
11. With record resolution and sensitivity, tool images how life organizes in a cell membrane

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Non GMO solution seafood allergies

(Date:11/5/2009)...ion of Biology Teachers (NABT) will recognize Leon... at Naugatuck Valley Community College (NVCC) in W...cation Award during the NABT annual professional d...09 in Denver, Colorado. , The Evolution Educatio...f Biological Sciences,(AIBS) and Biological Scien...
(Date:11/4/2009)...n natural science) , United States Using Less ... today than it did 35 years ago, despite a 30 perc... partly attributable to alternative cooling method...stems. According to the latest USGS water use repo...ates goes to cooling thermoelectric power plants. ...
(Date:11/4/2009)...ory that deciphered the DNA codes, or genomes, of ... has joined The Genome 10K Project, an internation... sequences on 10,000 species of animals for conduc... can not be achieved. , Participating in The Gen... the Nov. 5, 2009 issue of the Journal of Heredit...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2HowStuffWorks com Campaign Proves Determination and Curiosity More Powerful than Gravity 52421 1HowStuffWorks com Campaign Proves Determination and Curiosity More Powerful than Gravity 52421 2HowStuffWorks com Campaign Proves Determination and Curiosity More Powerful than Gravity 52421 3Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 1Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 2Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 3Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 4Genstar Capital Portfolio Company Univita Health Completes Debt Financing 52417 1Genstar Capital Portfolio Company Univita Health Completes Debt Financing 52417 2Genstar Capital Portfolio Company Univita Health Completes Debt Financing 52417 3
...vider Deploys Biometric Access Control Solution, ...ds, WALL, N.J., Sept. 30 BIO-key International,I...ss public safety,solutions and finger-based biomet...andolph ("Parente"), a leading accounting and cons...tity solution to secure their new,headquarters., ...
...roup led by Prof Makoto Tominaga and Dr Takaaki So...s (NIPS), Japan, found that a small fly, drosophil...roup reports their finding in Journal of Neurosci...nown how flies detect a noxious heat to avoid it. ...ainless" protein, which had been known to be impor...
...Federation of American Scientists (FAS) will reach...gically accurate immunology video game through a g.... This bold and fun game is available for download...o release the next version of Immune Attack in Feb... for the FAS Learning Technologies Program. "We,r...
Other Biology News:Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification 2Parente Randolph Secures Access to New Corporate Headquarters With BIO-key(R) Biometric Identification 3Entertainment Software Association Foundation awards grant to FAS for immune attack 2
(Date:11/4/2009)...LLE, Ala., Nov. 4 DIATHERIX Labora...today presented at the Michigan Security Network H...earborn, Mich. Dennis Grimaud, Chairman and Chief ...ct of the company,s advanced molecular diagnostic ...fectious disease diagnosis and military efforts. ...
(Date:11/4/2009)..., ROCKVILLE, Md., Nov. 4 Zyngenia...ocused on next-generation antibody drug developmen... in Series A funding from New Enterprise Associate...l firms. The capital will be used to create novel,...ss two or more biological targets with a single ag...
(Date:11/4/2009)...LOS, Calif., Nov. 4 Nekt...s financial results for the third quarter ended Se...ended September 30, 2009 improved to $31.0 million...$37.0 million or $0.40 per share in the third quar...rovements to its operating efficiencies as compare...
(Date:11/4/2009)...CITY, Nov. 4 /PRNewswire-FirstCall/ - Medicago Inc... developing highly effective and affordable vaccin... and Virus-Like Particles (VLPs), today announced ...tment of Health and Human Services (HHS) to presen...p (GHSI) on November 5, 2009 at 2:40 pm (EST) at t...
Breaking Biology Technology:DIATHERIX Laboratories Presents at Homeland Security Conference 2Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10Medicago to present at the U.S. Department of Health and Human Services' Global Health Security Initiative Workshop 2
...ogics platform for robust growth -, - Includes pr...rocessing facility -...n 2008 and $25 million in 2009; no dilution to e... in-process R&D charge -, SAN DI...al device company focused on developing products f...
...May 8 Pharmos Corporation,(Nasdaq: PARS ) today ... 31,2008. The Company recorded a net loss of $3.6 ...2008 compared to a net loss of $4.8 million, or $0... short-term investments,totaled $11.3 million at M...first quarter 2008 is due primarily to,a 29% decre...
..., May 8 Edwards Lifesciences,Corporation (NYSE: ...ves,announced that the company will celebrate a nu...uts at the 88th annual meeting of the American,Ass... San Diego., Among the milestones marked by Edwar...ary of partnering with clinicians to develop life-...
Other Biology Technology:NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 2NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 3NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 4NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 5NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 6Pharmos Corporation Reports 2008 First Quarter Results 2Pharmos Corporation Reports 2008 First Quarter Results 3Pharmos Corporation Reports 2008 First Quarter Results 4Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 2Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 3Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 4
Mouse Anti-Macrophage L1 protein Calprotectin Monoclonal Antibody, Unconjugated, Clone B314.1 (MAC 387) from Abcam
Mouse Anti-Human CYTOKERATIN 1-8 Monoclonal Antibody, Unconjugated, Clone Ks1-8 from AbD Serotec
Human Mesenchymal Stem Cell Functional Identification Kit from R&D Systems
BRIJ 35 - 1 Gallon from GeneTex
Biology Products: